Perspectives in adverse drug events (ADE) reporting: Nomenclature use and communications in ADE identification
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Presentation
- By: SUBRAMANIAM (Department of Veterans Affairs, Pharmacy Benefits Management SHG (119), Washington, United States of America)
Aims: To define ADEs and discuss their impact in the healthcare system. To identify nomenclature inconsistencies apparent in ADE reporting such as drug-induced illness, adverse drug effects, ADEs, and adverse drug reactions (ADRs) and examine communication tools for information dissemination for improved ADE reporting. To describe existing.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.